Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 7,610 shares at $90.58 ($703K) on 2018-08-20, disclosed to the SEC on 2018-08-21.
Open-market sale of $703k ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.58 | 572 | $52K | 7.4% |
| 2 | $90.58 | 572 | $52K | 7.4% |
| 3 | $91.49 | 700 | $64K | 9.1% |
| 4 | $92.68 | 2,224 | $206K | 29.3% |
| 5 | $92.68 | 2,224 | $206K | 29.3% |
| 6 | $93.49 | 659 |
| $62K |
| 8.8% |
| 7 | $93.49 | 659 | $62K | 8.8% |
| Total | $92.40 avg | 7,610 | $703K | 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |